PennantPark Investment Corporation Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2025 GlobeNewswire November 24, 2025 MIAMI, Nov. 24, 2025 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (NYSE: PNNT) (the “Company”) announced today financial results for the fourth quarter and fiscal year ended September 30, 2025. HIGHLIGHTS Year ended September 30, […]

ORIC(R) Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference GlobeNewswire November 24, 2025 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating

Fluence Energy, Inc. Reports 2025 Financial Results and Initiates 2026 Guidance GlobeNewswire November 24, 2025 ARLINGTON, Va., Nov. 24, 2025 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months and

Exodus Enters Next Phase as a Crypto Payments Company With Agreement to Acquire W3C Corp, and its subsidiaries Baanx and Monavate The company will acquire end-to-end payments infrastructure, positioning it to become an on-chain payments giant GlobeNewswire November 24, 2025 OMAHA, Neb., Nov. 24, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”

Zoom Communications Reports Financial Results for the Third Quarter of Fiscal Year 2026 GlobeNewswire November 24, 2025 Third quarter total revenue of $1,229.8 million, up 4.4% year over year as reported and 4.2% in constant currency Third quarter Enterprise revenue of $741.4 million, up 6.1% year over year Third quarter GAAP operating margin of 25.2%

Rani Therapeutics to Participate in the Evercore Healthcare Conference GlobeNewswire November 24, 2025 SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company's management team will participate in

Oxford to Release Third Quarter Fiscal 2025 Results on December 10, 2025 GlobeNewswire November 24, 2025 ATLANTA, Nov. 24, 2025 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE: OXM) today announced that it plans to release its third quarter fiscal 2025 financial results after the market close on Wednesday, December 10, 2025. Following the news release,

Sana Biotechnology to Present at December 2025 Investor Conferences GlobeNewswire November 24, 2025 SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in December. The presentations will feature

Lavoro Announces Receipt of Non-Compliance Notice from Nasdaq Regarding Delayed Filing of Form 20-F GlobeNewswire November 24, 2025 SÃO PAULO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Lavoro Limited (Nasdaq: LVRO, LVROW) announced today that, as expected, it received a notice of non-compliance (the “Notice”) from Nasdaq Stock Market LLC (“Nasdaq”) on November 19, 2025. The

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference GlobeNewswire November 24, 2025 BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate